Toenail onychomycosis: current and future treatment options
- 1 January 2007
- journal article
- review article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 20 (1), 31-46
- https://doi.org/10.1111/j.1529-8019.2007.00109.x
Abstract
Onychomycosis is a common disease affecting as much as 8% of the general population. Treatment of onychomycosis is challenging, complicated by low cure rates and relatively high relapse rates. This paper reviews the efficacy of current oral, topical, and surgical treatment options. Currently, the treatment of choice for toenail onychomycosis is oral terbinafine because of its high efficacy, low relapse rates, and cost-effectiveness. Oral itraconazole or fluconazole could be considered for infections caused by Candida. Topical therapies may be a useful adjunct to these systemic therapies, but are less effective when used alone. More research is needed to determine the best measures for preventing reinfection.Keywords
This publication has 95 references indexed in Scilit:
- Cost-effectiveness of diagnostic tests for toenail onychomycosis: A repeated-measure, single-blinded, cross-sectional evaluation of 7 diagnostic testsJournal of the American Academy of Dermatology, 2006
- Prevention of onychomycosis reinfection for patients with complete cure of all 10 toenails: Results of a double-blind, placebo-controlled, pilot study of prophylactic miconazole powder 2%Journal of the American Academy of Dermatology, 2005
- Pulse versus continuous terbinafine for onychomycosis: A randomized, double-blind, controlled trialJournal of the American Academy of Dermatology, 2005
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenailJournal of the American Academy of Dermatology, 1998
- Treatment of Candida nail infection with terbinafineJournal of the American Academy of Dermatology, 1996
- Traditional management of onychomycosisJournal of the American Academy of Dermatology, 1996
- Onychomycosis: A significant medical disorderJournal of the American Academy of Dermatology, 1996
- Terbinafine in onychomycosis of the toenail: A novel treatment protocolJournal of the American Academy of Dermatology, 1995
- Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactionsJournal of the American Academy of Dermatology, 1993
- Vitamin E and onychomycosisJournal of the American Academy of Dermatology, 1983